BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31210052)

  • 1. Leptin and adiponectin levels in obstructive sleep apnea phenotypes.
    Bingol Z; Karaayvaz EB; Telci A; Bilge AK; Okumus G; Kiyan E
    Biomark Med; 2019 Jul; 13(10):865-874. PubMed ID: 31210052
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome.
    Tokuda F; Sando Y; Matsui H; Koike H; Yokoyama T
    Intern Med; 2008; 47(21):1843-9. PubMed ID: 18981626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of leptin and adiponectin as disease markers in subjects with obstructive sleep apnea.
    Al Mutairi S; Mojiminiyi OA; Al Alawi A; Al Rammah T; Abdella N
    Dis Markers; 2014; 2014():706314. PubMed ID: 24982545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of obesity and obstructive sleep apnea on metabolic hormones.
    Sánchez-de-la-Torre M; Mediano O; Barceló A; Piérola J; de la Peña M; Esquinas C; Miro A; Durán-Cantolla J; Agustí AG; Capote F; Marin JM; Montserrat JM; García-Río F; Barbé F
    Sleep Breath; 2012 Sep; 16(3):649-56. PubMed ID: 21912907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-related changes of the epicardial fat thickness and leptin in obstructive sleep apnea.
    Akilli H; Kayrak M; Bekci TT; Erdogan Hİ; Aribas A; Yildirim O; Taner A; Erer M; Unlu A
    Echocardiography; 2014 Apr; 31(4):411-9. PubMed ID: 24304225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep-disordered breathing, systemic adipokine secretion, and metabolic dysregulation in overweight and obese children and adolescents.
    Van Eyck A; Van Hoorenbeeck K; De Winter BY; Van Gaal L; De Backer W; Verhulst SL
    Sleep Med; 2017 Feb; 30():52-56. PubMed ID: 28215263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cluster analysis identifies a pathophysiologically distinct subpopulation with increased serum leptin levels and severe obstructive sleep apnea.
    Kozu Y; Kurosawa Y; Yamada S; Fukuda A; Hikichi M; Hiranuma H; Akahoshi T; Gon Y
    Sleep Breath; 2021 Jun; 25(2):767-776. PubMed ID: 32886313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serum leptin level in non-obese patients with obstructive sleep apnea.
    Pamuk AE; Süslü AE; Yalçınkaya A; Öztaş YE; Pamuk G; Özer S; Önerci M
    Auris Nasus Larynx; 2018 Aug; 45(4):796-800. PubMed ID: 29174427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of obesity, different fat compartments and sleep apnea severity in circulating leptin levels: the Icelandic Sleep Apnea Cohort study.
    Arnardottir ES; Maislin G; Jackson N; Schwab RJ; Benediktsdottir B; Teff K; Juliusson S; Pack AI; Gislason T
    Int J Obes (Lond); 2013 Jun; 37(6):835-42. PubMed ID: 22964793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different obesity-related adipokines on the occurrence of obstructive sleep apnea.
    Xu X; Xu J
    Endocr J; 2020 May; 67(5):485-500. PubMed ID: 32307359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines in children with obstructive sleep apnea and the effects of treatment.
    Li AM; Ng C; Ng SK; Chan MM; So HK; Chan I; Lam CW; Ng PC; Wing YK
    Chest; 2010 Mar; 137(3):529-35. PubMed ID: 20022971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of OSA on biological markers in morbid obesity and metabolic syndrome.
    Salord N; Gasa M; Mayos M; Fortuna-Gutierrez AM; Montserrat JM; Sánchez-de-la-Torre M; Barceló A; Barbé F; Vilarrasa N; Monasterio C
    J Clin Sleep Med; 2014 Mar; 10(3):263-70. PubMed ID: 24634623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistin is closely related to systemic inflammation in obstructive sleep apnea.
    Yamamoto Y; Fujiuchi S; Hiramatsu M; Nishigaki Y; Takeda A; Fujita Y; Yamazaki Y
    Respiration; 2008; 76(4):377-85. PubMed ID: 18577878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea.
    Sánchez-de-la-Torre M; Barceló A; Piérola J; Esquinas C; de la Peña M; Durán-Cantolla J; Capote F; Masa JF; Marin JM; Vilá M; Cao G; Martinez M; de Lecea L; Gozal D; Montserrat JM; Barbé F
    Respir Med; 2011 Dec; 105(12):1954-60. PubMed ID: 21889324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea.
    Wolk R; Svatikova A; Nelson CA; Gami AS; Govender K; Winnicki M; Somers VK
    Obes Res; 2005 Jan; 13(1):186-90. PubMed ID: 15761179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of obesity hypoventilation syndrome in obese subjects with obstructive sleep apnea.
    Bingol Z; Pıhtılı A; Cagatay P; Okumus G; Kıyan E
    Respir Care; 2015 May; 60(5):666-72. PubMed ID: 25587164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of the severity of obstructive sleep apnea with plasma leptin levels.
    Ozturk L; Unal M; Tamer L; Celikoglu F
    Arch Otolaryngol Head Neck Surg; 2003 May; 129(5):538-40. PubMed ID: 12759266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diurnal variation of serum leptin and adiponectin in nontreated obstructive sleep apnea disease: a prospective observational study.
    Macrea M; Martin T; Misra H
    Conn Med; 2014 Feb; 78(2):69-72. PubMed ID: 24741853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians.
    Bhatt SP; Guleria R; Vikram NK; Gupta AK
    Sleep Breath; 2019 Mar; 23(1):171-178. PubMed ID: 30032465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea.
    Schäfer H; Pauleit D; Sudhop T; Gouni-Berthold I; Ewig S; Berthold HK
    Chest; 2002 Sep; 122(3):829-39. PubMed ID: 12226021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.